Dow Up 0.82% Nasdaq Up 0.70%

Incyte Corporation (INCY)

-NasdaqGS
83.16 Up 1.89(2.33%) 4:00PM EDT
|After Hours : 83.16 0.00 (0.00%) 4:24PM EDT
Prev Close:81.27
Open:81.31
Bid:60.09 x 100
Ask:85.00 x 400
1y Target Est:91.57
Beta:0.5598
Earnings Date:Aug 2 - Aug 8 (Est.)
Day's Range:80.64 - 83.50
52wk Range:55.00 - 133.62
Volume:1,314,747
Avg Vol (3m):1,409,220
Market Cap:15.60B
P/E (ttm):335.32
EPS (ttm):0.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INCYUp 2.33%15.60B
CELGUp 1.36%81.42B
AMGNUp 1.87%116.87B

Key Statistics

Forward P/E (1 yr):64.47
P/S (ttm):17.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.01
Quarterly EPS Est (Jun-16) :-0.01
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-196.49

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics in oncology. It offers JAKAFI for the treatment of myelofibrosis and polycythemia vera cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback